Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

63.08 USD +0.29 (+0.46%)
Streaming Delayed Price Updated: 8:39 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Positive news on COVID vaccines weighs against concerns over new variants
The COVID-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE has proved to be as effective in the real world as it was in clinical trials in the first major study of the two-dose... 
Tags JNJ REGN GSK
From MarketWatch
3 Top-Rated Value Stocks to Buy in March
Growth stocks have delivered a stellar performance since the stock market retreat in mid-March. 
Tags Consumer Goods Healthcare Stocks / Equities
From Blogs - TalkMarkets
Is Galapagos Stock a Bad-News Buy Right Now?
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices. 
Tags GILD GLPG Market News
From Motley Fool
Noteworthy ETF Inflows: IBB, GILD, MRNA, ILMN
Symbols mentioned in this story: IBB, GILD, MRNA, ILMN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Lantern Pharma CEO Discusses The Addition Of Its New ADC Program And The Resurgence Of ADC Therapy For Cancer Treatment
The following article is sponsored by Lantern Pharma. The information contained in this article in no way represents investment advice ... 
Tags Market News Markets LTRN
From Benzinga
Your 2 Best Profit Opportunities in 2021
Infinity Pharmaceuticals is my pick for Stock of the Year. And Shopify is my selection for Stock of the Decade. 
Tags SHOP RHHBY AMZN
From Motley Fool
Big Tech is swallowing the rest of Silicon Valley
Silicon Valley's deepening descent into wealth inequality is particularly stark when comparing Big Tech with the San Francisco Bay Area's small businesses. 
Tags CRM GOOG FB
From MarketWatch
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the ... 
Tags Benzinga BMY Health Care
From Benzinga
3 Biotech Stocks to Buy As Things Heat Up for the Sector
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Biotech stocks offer a textbook retracement pattern. The risk is low, and... 
Tags XBI GILD Market News
From InvestorPlace
UN chief joins WHO in slamming rich countries for hogging COVID vaccines
The head of the United Nations has sharply criticized developed countries for hogging COVID-19 vaccines and called for a global effort to get all people in all countries vaccinated as soon as... 
Tags PFE BNTX SPX
From MarketWatch
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
The biotech will get $345 million through an upfront payment and equity investment. 
Tags GILD Market News VIR
From Motley Fool
Here's What Caused Royalty Pharma's Mixed Results in Q4
The company's royalties revenue soared, but its earnings sank. 
Tags RPRX Market News GILD
From Motley Fool
Notable Tuesday Option Activity: GTHX, EXPI, GILD
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in G1 Therapeutics Inc (GTHX), where a total volume of 13,184 contracts has been... 
Tags Stocks
From Market News Video
These 3 Stocks Just Announced Dividend Increases That Boosted My Passive Income
Here are three stocks that are increasing dividends paid to their shareholders. 
Tags Stocks / Equities
From Blogs - TalkMarkets
10 Biggest Price Target Changes For Thursday
Morgan Stanley raised Simon Property Group Inc (NYSE: SPG) price target from $88 to $125. Simon Property shares rose 0.9% to $107.15 ... 
Tags Benzinga ANAB CERN
From Benzinga
Two-Third Patients Experienced No CRS/Neurologic Events Up To Three Days After Yescarta, New Data From LBCL Study Shows
Kite, aGilead Sciences Inccompany (NASDAQ:GILD), hasannounced new datafromthe ZUMA-1 Phase 1/2 ... 
Tags Benzinga General anaplastic large cell lymphoma
From Benzinga
4 Top COVID Stocks to Buy in February
Are you a high-risk stock picker or cautious investor? No matter your answer, there's a stock for you on this list. 
Tags Market News GILD REGN
From Motley Fool
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
A huge pivot could reopen doors to growth that seemed closed. 
Tags REGN Market News LLY
From Motley Fool
Gilead Sciences and Galapagos Shutter Their Pulmonary Fibrosis Program
Despite solid signs of efficacy in mid-stage trials, the partners are shutting down all clinical trials with ziritaxestat. 
Tags GILD GLPG Market News
From Motley Fool
Galapagos, Gilead Sciences Pull Plug On Ziritaxestat Clinical Trials
Galapagos NV(NASDAQ:GLPG) andGilead Sciences Inc(NASDAQ:GILD) havedecided to stopthe ... 
Tags GLPG GILD Phase 3
From Benzinga
Notable ETF Outflow Detected - IBB, GILD, MRNA, ILMN
Symbols mentioned in this story: IBB, GILD, MRNA, ILMN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Key Dividend Increases From Last Week Including GSK, DEO, DGX, PRU, GILD
Stocks that raised dividends. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
Eli Lilly’s antibody treatments have received an emergency use authorization from the United States Food and Drug Administration. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
3 Best Biotech Stocks to Buy Now
These biotechs are developing innovative therapies while doing their part to combat the coronavirus. 
Tags GILD IBB Market News
From Motley Fool
What Are Pfizer's Prospects in 2021 and Beyond?
Hint: Better than the company's recent Q4 results might make you think. 
Tags GSK GILD Market News
From Motley Fool
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
Eli Lilly and Co (NYSE: LLY)’s antibody treatments have received an emergency use authorization from the United States Food and ... 
Tags News Benzinga Bamlanivimab
From Benzinga
Jaguar Health Isn’t a Healthy Investment, but It Could Be a Profitable One
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Likely, no one would suggest that JAGX stock is a fundamentally sound... 
Tags REGN NASDAQ:JAGX,NYSE:PFE,NASDAQ:MRNA,NASDAQ:GILD,NASDAQ:REGN MRNA
From InvestorPlace
Forget Gamestop! This Highly Shorted Stock Is a Strong Buy Now
The unusual biotech could be a bitter pill for short sellers to swallow. 
Tags GILD JAZZ Market News
From Motley Fool
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?
Teva Pharmaceutical Industries Limited is scheduled to report fourth-quarter and full-year 2020 results on Feb 10, before market open. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
Healthcare Sector Lags But Small Caps Are Strong
Small cap stocks continued to soar with optimism for the longer term and speculation rampant. The market rally gained more momentum over the past week; the energy sector was up 8.29%, industrials up... 
Tags Healthcare Pharma/Biotech ETFs
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.